Interstitial Lung Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years of age or older
- You have been diagnosed with Idiopathic Pulmonary Fibrosis (IPF) — a type of lung scarring disease — at any stage of severity, based on the most recent international guidelines from 2022
Who may not be able to join:
- You do not wish to take part in the study
- You are not able to give your own consent to participate in the study
- You have had a sudden worsening (flare-up) of your IPF in the 6 months before joining the trial
- You have previously been diagnosed with a long-term airway condition such as asthma, chronic obstructive pulmonary disease (COPD), or bronchiectasis (unless the bronchiectasis is caused by IPF itself)
- Your breathing tests show a specific type of airflow blockage in your lungs (confirm with trial site)
- You are currently taking long-acting inhaler medicines to open your airways, or a combination inhaler containing both an airway-opener and a steroid
- You are not able to reliably complete standard breathing/lung function tests
- You are currently taking steroid tablets or capsules (such as prednisone) or medicines that suppress your immune system on a long-term basis
- You have been diagnosed with cancer in your lungs or the lining around your lungs
- You are currently pregnant or breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Prevalence of small airway disease in a group of patients with IPF at the time of diagnosis, before the initiation of antifibrotic therapy.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.